These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26433214)

  • 1. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
    Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
    Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
    Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
    Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Fornai M; Colucci R; Tirotta E; Blandini F; Levandis G; Cerri S; Segnani C; Ippolito C; Bernardini N; Cseri K; Blandizzi C; Haskó G; Antonioli L
    J Neuroinflammation; 2016 Jun; 13(1):146. PubMed ID: 27295950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
    Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
    Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.
    Colucci M; Cervio M; Faniglione M; De Angelis S; Pajoro M; Levandis G; Tassorelli C; Blandini F; Feletti F; De Giorgio R; Dellabianca A; Tonini S; Tonini M
    Auton Neurosci; 2012 Aug; 169(2):77-86. PubMed ID: 22608184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.
    Blandini F; Balestra B; Levandis G; Cervio M; Greco R; Tassorelli C; Colucci M; Faniglione M; Bazzini E; Nappi G; Clavenzani P; Vigneri S; De Giorgio R; Tonini M
    Neurosci Lett; 2009 Dec; 467(3):203-7. PubMed ID: 19835930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of nerve pathways mediating colorectal dysfunction in Parkinson's disease model produced by lesion of nigrostriatal dopaminergic neurons.
    Chai XY; Diwakarla S; Pustovit RV; McQuade RM; Di Natale M; Ermine CM; Parish CL; Finkelstein DI; Furness JB
    Neurogastroenterol Motil; 2020 Sep; 32(9):e13893. PubMed ID: 32512642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substantia nigra modulates proximal colon tone and motility in a vagally-dependent manner in the rat.
    Xing T; Nanni G; Burkholder CR; Browning KN; Travagli RA
    J Physiol; 2023 Nov; 601(21):4751-4766. PubMed ID: 37772988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.
    Fornai M; Pellegrini C; Antonioli L; Segnani C; Ippolito C; Barocelli E; Ballabeni V; Vegezzi G; Al Harraq Z; Blandini F; Levandis G; Cerri S; Blandizzi C; Bernardini N; Colucci R
    J Pharmacol Exp Ther; 2016 Feb; 356(2):434-44. PubMed ID: 26582732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.
    Toti L; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1013-23. PubMed ID: 25277799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Ippolito C; Segnani C; Dolfi A; Errede M; Virgintino D; Fornai M; Antonioli L; Garelli F; Nericcio A; Colucci R; Cerri S; Blandini F; Blandizzi C; Bernardini N
    Neurobiol Dis; 2020 Jun; 139():104821. PubMed ID: 32088380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
    Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
    Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.
    Zhang X; Li Y; Liu C; Fan R; Wang P; Zheng L; Hong F; Feng X; Zhang Y; Li L; Zhu J
    Transl Res; 2015 Aug; 166(2):152-62. PubMed ID: 25766133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.
    Bove C; Anselmi L; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2019 Jul; 317(1):G1-G7. PubMed ID: 31042398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
    Pellegrini C; Antonioli L; Colucci R; Tirotta E; Gentile D; Ippolito C; Segnani C; Levandis G; Cerri S; Blandini F; Barocelli E; Ballabeni V; Bernardini N; Blandizzi C; Fornai M
    Neuropharmacology; 2017 Sep; 123():22-33. PubMed ID: 28526609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion.
    Boix J; Padel T; Paul G
    Behav Brain Res; 2015 May; 284():196-206. PubMed ID: 25698603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.